ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
55 Boulevard Diderot – Paris – 75012
VAT: FR95267500452
http://www.aphp.fr
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS has received € 8,195,721.0 for its participation in a total of 14 project(s) with a total cost of € 367,060,359.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-01 | 101021957 | NIGHTINGALE | emergency medicine | 2024-09-30 | participant | € 312,625.0 | € 8,831,477 | 2 | 26 | CORDIS ↪ |
| 2018-01-01 | 754740 | MOODSTRATIFICATION | psychiatry | 2023-06-30 | participant | € 688,125.0 | € 5,963,750 | 1 | 12 | CORDIS ↪ |
| 2018-06-01 | 786670 | NO FEAR | emergency medicine · critical care medicine | 2023-05-31 | participant | € 137,525.0 | € 3,495,957 | 2 | 18 | CORDIS ↪ |
| 2020-01-01 | 871245 | SPRING | autonomous robots · health care services | 2024-05-31 | participant | € 784,473.75 | € 8,360,385 | 1 | 8 | CORDIS ↪ |
| 2021-06-01 | 899991 | RITA-MI 2 | mortality · immunology · cardiovascular diseases | 2026-05-31 | participant | € 2,569,325.75 | € 6,583,216 | 1 | 14 | CORDIS ↪ |
| 2018-01-01 | 777554 | ID-EPTRI | drug discovery · governance · paediatrics | 2020-04-30 | participant | € 147,500.0 | € 3,071,250 | 1 | 32 | CORDIS ↪ |
| 2018-01-01 | 755170 | RECOMB | gene therapy · immunology · stem cells · graft versus host disease · transplantation | 2022-12-31 | participant | € 25,000.0 | € 5,990,460 | 1 | 17 | CORDIS ↪ |
| 2019-11-01 | 853966 | EU-PEARL | governance · tuberculosis | 2023-04-30 | participant | € 619,749.13 | € 25,938,047 | 1 | 41 | CORDIS ↪ |
| 2019-01-01 | 825821 | iReceptor Plus | autoimmune diseases · vaccines · oncology · personalized medicine · immunotherapy | 2022-12-31 | participant | € 556,875.0 | € 8,505,675 | 6 | 21 | CORDIS ↪ |
| 2017-09-01 | 766214 | META-CAN | drug discovery · entrepreneurship · cell metabolism · immunology · oncology | 2021-08-31 | participant | € 0.0 | € 3,831,957 | 3 | 20 | CORDIS ↪ |
| 2017-11-01 | 777377 | LITMUS | drug discovery · diabetes · hepatology · obesity | 2023-10-31 | participant | € 323,000.0 | € 47,281,406 | 1 | 60 | CORDIS ↪ |
| 2018-04-01 | 777500 | IMI-PainCare | drug discovery · surgery · pharmaceutical drugs · pathophysiology · pharmacokinetics | 2023-03-31 | participant | € 295,037.5 | € 23,405,673 | 1 | 41 | CORDIS ↪ |
| 2018-06-01 | 777394 | AIMS-2-TRIALS | epilepsy · personalized medicine | 2025-05-31 | participant | € 997,102.33 | € 115,441,584 | 1 | 57 | CORDIS ↪ |
| 2019-01-01 | 825575 | EJP RD | ecosystems | 2023-12-31 | participant | € 739,385.51 | € 100,359,517 | 2 | 157 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS has received € 1,895,998.0 for its participation in a total of 6 project(s) with a total cost of € 197,138,133.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | 101046133 | ISIDORe | infectious diseases · pandemics · structural biology | 2025-07-31 | participant | € 1,437.5 | € 20,998,624 | 1 | 159 | CORDIS ↪ |
| 2023-05-01 | 101104582 | IntReALL 2020 | mortality · databases · leukemia | 2028-04-30 | participant | € 100,000.0 | € 6,135,176 | 1 | 26 | CORDIS ↪ |
| 2023-11-01 | 101080229 | DREAMS | drug discovery · artificial intelligence · stem cells · neurology | 2028-10-31 | participant | € 226,250.0 | € 6,952,110 | 1 | 9 | CORDIS ↪ |
| 2024-01-01 | 101136299 | ARTEMIS | infectious diseases · hepatology · cardiology | 2027-12-31 | participant | € 424,937.0 | € 9,365,096 | 1 | 21 | CORDIS ↪ |
| 2024-09-01 | 101156595 | ERDERA | ecosystems | 2031-08-31 | participant | € 808,416.25 | € 145,830,619 | 2 | 178 | CORDIS ↪ |
| 2022-09-01 | 101057385 | R2D2-MH | neurobiology · psychiatry · epidemiology · cell biology · social inequalities | 2027-08-31 | participant | € 334,958.0 | € 7,856,507 | 2 | 27 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS has received € 4,748,288.0 for its participation in a total of 10 project(s) with a total cost of € 304,695,395.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-01-01 | 223115 | SHELTER | nursing · databases | 2011-12-31 | participant | € 187,440.0 | € 3,025,598 | 1 | 8 | CORDIS ↪ |
| 2009-01-01 | 223590 | PAIN-OUT | databases | 2012-12-31 | participant | € 144,000.0 | € 3,829,100 | 1 | 18 | CORDIS ↪ |
| 2010-01-01 | 241796 | SATURN | bacteriology · antibiotics · antibiotic resistance | 2014-12-31 | participant | € 235,389.74 | € 7,821,538 | 1 | 16 | CORDIS ↪ |
| 2009-06-15 | 115003 | SAFE-T | data science · databases · pathology · modeling of diseases spread | 2015-06-14 | participant | € 2,039,152.0 | € 36,427,294 | 1 | 26 | CORDIS ↪ |
| 2011-10-01 | 282512 | R-GNOSIS | public health · surgical specialties · antibiotics · multidrug resistance · antibiotic resistance | 2017-03-31 | participant | € 242,510.0 | € 15,654,161 | 2 | 24 | CORDIS ↪ |
| 2012-03-01 | 115303 | ABIRISK | rheumatology · databases · immunisation · multiple sclerosis · gastroenterology | 2018-02-28 | participant | € 435,626.0 | € 32,851,056 | 2 | 38 | CORDIS ↪ |
| 2010-11-01 | 261472 | STOPENTERICS | genetics · proteomics · infectious diseases · vaccines | 2017-12-31 | participant | € 313,892.02 | € 16,055,468 | 2 | 18 | CORDIS ↪ |
| 2013-02-01 | 309820 | NANOATHERO | drug discovery · arteriosclerosis · nanomedicine · stroke | 2018-07-31 | participant | € 430,873.6 | € 12,993,053 | 1 | 16 | CORDIS ↪ |
| 2009-03-01 | 223060 | NEUROSIS | mortality | 2015-08-31 | participant | € 391,086.8 | € 7,379,459 | 1 | 15 | CORDIS ↪ |
| 2015-01-01 | 115737 | COMBACTE-MAGNET | epidemics prevention · critical care medicine · antibiotics · multidrug resistance · antibiotic resistance | 2021-12-31 | participant | € 328,320.0 | € 168,658,666 | 1 | 40 | CORDIS ↪ |